Vietnam Medical and Pharmaceutical Investment JSC (HOSE:JVC)

HOSE:JVC Revenue

Vietnam Medical and Pharmaceutical Investment JSC had revenue of 159.13B VND in the quarter ending March 31, 2026, a decrease of -12.16%. This brings the company's revenue in the last twelve months to 741.12B, up 9.92% year-over-year. In the year 2025, Vietnam Medical and Pharmaceutical Investment JSC had annual revenue of 763.15B with 24.79% growth.

• Revenue (ttm): 741.12B
• Revenue Growth: +9.92%
• P/S Ratio: 0.53
• Revenue / Employee: 4.26B
• Employees: 174
• Market Cap: 389.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	763.15B	151.61B	24.79%
Jan 1, 2025	611.54B	35.25B	6.12%
Jan 1, 2024	576.29B	76.85B	15.39%
Mar 31, 2017	499.43B	-7.91B	-1.56%
Mar 31, 2016	507.34B	-385.84B	-43.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error